We are a new group of chemical biologists at Queen Mary University looking at developing small molecules that help us understand and modulate biology
(Tate Group, Imperial College, 2022)
Funding
- Royal Society International Exchange (with Prof Page) (2024)
- Royal Society Research Grant (2024)
- RSC Research Development Grant (2023)
- BBSRC Flexible Talent Mobility Account (2022, Imperial College)
- Worldwide Cancer Research (2022, Covalent small molecules targeting Rab27 to prevent cancer metastasis)
- Marie Skłodowska-Curie Individual Fellowship (2020, RabTarget4Metastasis)
EDV Lab 